Transcatheter Aortic Valve Replacement Global Market Report 2023: Featuring Abbott, Edwards Lifesciences, Boston Scientific & More

Blog

HomeHome / Blog / Transcatheter Aortic Valve Replacement Global Market Report 2023: Featuring Abbott, Edwards Lifesciences, Boston Scientific & More

Sep 17, 2023

Transcatheter Aortic Valve Replacement Global Market Report 2023: Featuring Abbott, Edwards Lifesciences, Boston Scientific & More

Global Transcatheter Aortic Valve Replacement Market Dublin, March 16, 2023

Global Transcatheter Aortic Valve Replacement Market

Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Transcatheter Aortic Valve Replacement Market Size, Share & Trends Analysis Report By Implantation Procedure (Transfemoral, Transapical, Transaortic), By Material, By Mechanism, By End-Use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.The global transcatheter aortic valve replacement market size is expected to reach USD 10.2 billion by 2030, expanding at 7.2% CAGR from 2023 to 2030.

The rising geriatric population and the prevalence of risk factors like aortic valve stenosis (AS) and other diseases continue to drive the demand for transcatheter aortic valve replacement (TAVR) procedures.

According to the World Heart Federation 2022, rheumatic heart disease affected 39 million individuals globally. It is a disorder in which rheumatic fever permanently damages the heart valves. According to a January 2022 published study titled 'As a result of these figures, the demand for TAVR is expected to rise in the coming years, contributing to the market's expansion. Furthermore, the rising prevalence of heart valve disease and increased regulatory approvals for novel and sophisticated TAVR devices drive market growth.

The rising prevalence of AS disease is a main factor driving the market's expansion. For instance, in January 2022, JenaValve Technology, Inc. formed a strategic alliance with an exclusive technology licensing agreement with Peijia Medical Limited in China. According to the terms of the deal, Peijia has been granted exclusive rights in China to produce and distribute JenaValve's Trilogy TAVR systems for treating patients with significant symptomatic aortic regurgitation (AR) and severe symptomatic AS.Transcatheter Aortic Valve Replacement Market Report Highlights

Based on the implantation procedure, the transfemoral segment held the largest market share of 53.6% in terms of revenue in 2022. Transfemoral is the most performed procedure in comparison with transapical, transaortic, and other implantation procedures. Moreover, smaller profile devices and expandable sheaths can be successfully delivered via the transfemoral technique

Based on material, the nitinol segment held the largest market share of 41.8% in 2022. Nitinol has strong biological and elastic properties, making it an ideal material for transcatheter heart valves

Based on the mechanism, the balloon-expandable valve segment held the largest market share of 57% in 2022. It promises robust growth due to its higher gradients when deployed in bicuspid anatomies and due to an increase in the rate of annular ruptures

Based on end-use, the hospital segment accounted for the largest market share of 90.3% in 2022. This is mainly due to the increasing patient base, increased TAVR procedures undertaken in hospitals, and favorable reimbursement scenarios

In 2022, North America dominated the global market with a share of around 38.2%. The primary drivers for market expansion are the rising prevalence of heart valve illness, the increased number of heart valve replacement procedures, product advancements, and the well-established healthcare infrastructure

According to the 2022 American College of Cardiology Foundation, the prevalence of AS is increasing in the U.S., with more than 1.5 million individuals in the U.S. suffering from AS

Key Attributes:

Report Attribute

Details

No. of Pages

100

Forecast Period

2022 - 2030

Estimated Market Value (USD) in 2022

$5714.3 Million

Forecasted Market Value (USD) by 2030

$10200 Million

Compound Annual Growth Rate

7.2%

Regions Covered

Global

Key Topics Covered: Chapter 1 Report Scope And Objectives Chapter 2 Methodology Chapter 3 Executive Summary Chapter 4 Market Variables, Trends & Scope Chapter 5 Transcatheter Aortic Valve Replacement Market: Implantation Procedure Analysis5.1 Transcatheter Aortic Valve Replacement Implantation Procedure Market Share Analysis, 2022 & 20305.2 Transcatheter Aortic Valve Replacement Implantation Procedure Market: Segment Dashboard:5.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Implantation Procedure Segment5.3.1 Transfemoral5.3.2 Transapical5.3.3 TransaorticChapter 6 Transcatheter Aortic Valve Replacement Market: Material Analysis6.1 Transcatheter Aortic Valve Replacement Material Market Share Analysis, 2022 & 20306.2 Transcatheter Aortic Valve Replacement Material Market: Segment Dashboard:6.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Material Segment6.3.1 Nitinol6.3.2 Cobalt Chromium6.3.3 Stainless Steel6.3.4 OthersChapter 7 Transcatheter Aortic Valve Replacement Market: Mechanism Analysis7.1 Transcatheter Aortic Valve Replacement Mechanism Market Share Analysis, 2022 & 20307.2 Transcatheter Aortic Valve Replacement Mechanism Market: Segment Dashboard:7.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Mechanism Segment7.3.1 Balloon-Expanding Valve7.3.2 Self-Expanding ValveChapter 8 Transcatheter Aortic Valve Replacement Market: End-Use Analysis8.1 Transcatheter Aortic Valve Replacement End-Use Market Share Analysis, 2022 & 20308.2 Transcatheter Aortic Valve Replacement End-Use Market: Segment Dashboard:8.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The End-Use Segment8.3.1 Hospitals8.3.2 Ambulatory Surgical Centers8.3.3 OthersChapter 9 Transcatheter Aortic Valve Replacement Market: Regional Analysis Chapter 10 Competitive Analysis Companies Mentioned

Abbott Laboratories, Inc

Edwards Lifesciences Corporation

Boston Scientific Corporation

Meril Life Sciences Pvt. Ltd., Inc

St. Jude Medical, Inc.

Medtronic Plc

Jenavalve Technology, Inc.

Bracco Spa

Transcatheter Technologies Gmbh

For more information about this report visit https://www.researchandmarkets.com/r/j3c2rd

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

Global Transcatheter Aortic Valve Replacement Market

ResearchAndMarkets.com's Transcatheter Aortic Valve Replacement Market Report Highlights Key Attributes: Report Attribute Details Key Topics Covered: Chapter 1 Report Scope And Objectives Chapter 2 Methodology Chapter 3 Executive Summary Chapter 4 Market Variables, Trends & Scope Chapter 5 Transcatheter Aortic Valve Replacement Market: Implantation Procedure Analysis Chapter 6 Transcatheter Aortic Valve Replacement Market: Material Analysis Chapter 7 Transcatheter Aortic Valve Replacement Market: Mechanism Analysis Chapter 8 Transcatheter Aortic Valve Replacement Market: End-Use Analysis Chapter 9 Transcatheter Aortic Valve Replacement Market: Regional Analysis Chapter 10 Competitive Analysis Companies Mentioned About ResearchAndMarkets.com Attachment